Tag: Chantix

Lawsuit Over Pfizer’s Disclosures Before Chantix Recall Is Dismissed

NEW YORK—A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc. of failing to disclose the presence of cancer-causing agents in Chantix before recalling the anti-smoking drug. U.S. District Judge Denise Cote in Manhattan found no plausible allegations that Pfizer had a duty to disclose that Chantix was…


Pfizer Expands Recall of Anti-Smoking Drug Containing Cancer-Linked Nitrosamine

Pfizer has announced a recall of the anti-smoking treatment Chantix due to the presence of unacceptably high levels of N-nitroso-varenicline, a substance whose long-term use has been linked to a higher risk of cancer. The drugmaker said on Sept. 16 that it is voluntarily recalling all lots of 0.5 mg and 1 mg Chantix tablets distributed…